We are moving -- at the end of October 2019 from Hopkins,MN to Shoreview, MN.
Shoreview Office Beginning November 2019 --
4700 Lexington Ave, Ste C until Spring 2020 when have larger office in same building, Shoreview MN, 55126
Dr. Dorff was a contributing chapter specialist author for the EDS book Disjointed.
Dr. Dorff was also a co-author on the first international consensus statement on MCAS
Diagnosis of mast cell activation syndrome: a global “consensus-2”
Lawrence B. Afrin, et al. DOI: https://doi.org/10.1515/dx-2020-0005. | Published online: 22 Apr 2020
Shanda R. Dorff & Lawrence B. Afrin (2020): Mast cell activation syndrome in pregnancy, delivery, postpartum and lactation: a narrative review, Journal of Obstetrics and Gynaecology, DOI: 10.1080/01443615.2019.1674259
Afrin LB, Ackerley MB, Bluestein LS, Brewer JH, Brook JB, Buchanan AD, Cuni JR, Davey WP, Dempsey TT, Dorff SR, Dubravec MS, Guggenheim AG, Hindman KJ, Hoffman B, Kaufman DL, Kratzer SJ, Lee TM, Marantz MS, Maxwell AJ, McCann KK, McKee DL, Menk Otto L, Pace LA, Perkins DD, Radovsky L, Raleigh MS, Rapaport SA, Reinhold EJ, Renneker ML, Robinson WA, Roland AM, Rosenbloom ES, Rowe PC, Ruhoy IS, Saperstein DS, Schlosser DA, Schofield JR, Settle JE, Weinstock LB, Wengenroth M, Westaway M, Xi SC, Molderings GJ. Diagnosis of mast cell activation syndrome: a global “consensus-2.” Diagnosis 2020, in press.
Afrin LB, Dempsey TT, Rosenthal L, Dorff SR. Successful mast-cell-targeted treatment of chronic dyspareunia, vaginitis, and dysfunctional uterine bleeding. J Obstetr Gynaecol 2018.